Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 33

1.

Schizophrenia-associated Risk and Protective Variants of c-Fos Encoding Gene.

Boyajyan A, Zakharyan R, Atshemyan S, Chavushyan A, Mkrtchyan G.

Recent Adv DNA Gene Seq. 2015 Feb 22. [Epub ahead of print]

PMID:
25706621
2.

Risk and protective effects of the complexin-2 gene and gene-environment interactions in schizophrenia.

Zakharyan R, Atshemyan S, Boyajyan A.

Recent Adv DNA Gene Seq. 2014;8(1):30-4.

PMID:
25564026
3.

Brain-derived neurotrophic factor blood levels are decreased in schizophrenia patients and associate with rs6265 genotypes.

Zakharyan R, Boyajyan A.

Clin Biochem. 2014 Aug;47(12):1052-5. doi: 10.1016/j.clinbiochem.2014.03.021. Epub 2014 Apr 5.

PMID:
24713399
4.

Functional genetic polymorphisms of monocyte chemoattractant protein 1 and C-C chemokine receptor type 2 in ischemic stroke.

Arakelyan A, Zakharyan R, Hambardzumyan M, Petrkova J, Olsson MC, Petrek M, Boyajyan A.

J Interferon Cytokine Res. 2014 Feb;34(2):100-5. doi: 10.1089/jir.2013.0030. Epub 2013 Oct 1.

PMID:
24083412
5.

Inflammatory cytokine network in schizophrenia.

Zakharyan R, Boyajyan A.

World J Biol Psychiatry. 2014 Apr;15(3):174-87. doi: 10.3109/15622975.2013.830774. Epub 2013 Sep 16. Review.

PMID:
24041158
6.

The netrin G1 gene rs628117 polymorphism is associated with ischemic stroke.

Stepanyan A, Zakharyan R, Boyajyan A.

Neurosci Lett. 2013 Aug 9;549:74-7. doi: 10.1016/j.neulet.2013.05.066. Epub 2013 Jun 12.

PMID:
23769687
7.

Interleukin-6 promoter polymorphism and plasma levels in patients with schizophrenia.

Zakharyan R, Petrek M, Arakelyan A, Mrazek F, Atshemyan S, Boyajyan A.

Tissue Antigens. 2012 Aug;80(2):136-42. doi: 10.1111/j.1399-0039.2012.01886.x. Epub 2012 May 10.

PMID:
22571276
8.

Monocyte chemoattractant protein-1 in schizophrenia: -2518A/G genetic variant and protein levels in Armenian population.

Zakharyan R, Boyajyan A, Arakelyan A, Melkumova M, Mrazek F, Petrek M.

Cytokine. 2012 Jun;58(3):351-4. doi: 10.1016/j.cyto.2012.02.013. Epub 2012 Mar 17.

PMID:
22425139
9.

Association of C1QB gene polymorphism with schizophrenia in Armenian population.

Zakharyan R, Khoyetsyan A, Arakelyan A, Boyajyan A, Gevorgyan A, Stahelova A, Mrazek F, Petrek M.

BMC Med Genet. 2011 Sep 28;12:126. doi: 10.1186/1471-2350-12-126.

10.

Functional characterization of the complement receptor type 1 and its circulating ligands in patients with schizophrenia.

Arakelyan A, Zakharyan R, Khoyetsyan A, Poghosyan D, Aroutiounian R, Mrazek F, Petrek M, Boyajyan A.

BMC Clin Pathol. 2011 Aug 25;11:10. doi: 10.1186/1472-6890-11-10.

11.

Functional variants of the genes involved in neurodevelopment and susceptibility to schizophrenia in an Armenian population.

Zakharyan R, Boyajyan A, Arakelyan A, Gevorgyan A, Mrazek F, Petrek M.

Hum Immunol. 2011 Sep;72(9):746-8. doi: 10.1016/j.humimm.2011.05.018. Epub 2011 May 24.

PMID:
21641949
12.

Genetic variants of the inflammatory C-reactive protein and schizophrenia in Armenian population: a pilot study.

Zakharyan R, Chavushyan A, Khoyetsyan A, Stahelova A, Arakelyan A, Boyajyan A, Mrazek F, Petrek M.

Int J Immunogenet. 2010 Oct;37(5):407-10. doi: 10.1111/j.1744-313X.2010.00942.x. Epub 2010 Jun 21.

PMID:
21182750
13.

Tocopherol esters inhibit human glutathione S-transferase omega.

Sampayo-Reyes A, Zakharyan RA.

Acta Biochim Pol. 2006;53(3):547-52. Epub 2006 Oct 1.

14.

Glutathione-S-transferase-omega [MMA(V) reductase] knockout mice: enzyme and arsenic species concentrations in tissues after arsenate administration.

Chowdhury UK, Zakharyan RA, Hernandez A, Avram MD, Kopplin MJ, Aposhian HV.

Toxicol Appl Pharmacol. 2006 Nov 1;216(3):446-57. Epub 2006 Jul 7.

PMID:
16930657
15.

Inhibition of human glutathione S-transferase omega by tocopherol succinate.

Sampayo-Reyes A, Zakharyan RA.

Biomed Pharmacother. 2006 Jun;60(5):238-44. Epub 2006 May 24.

PMID:
16781109
16.

Interactions of sodium selenite, glutathione, arsenic species, and omega class human glutathione transferase.

Zakharyan RA, Tsaprailis G, Chowdhury UK, Hernandez A, Aposhian HV.

Chem Res Toxicol. 2005 Aug;18(8):1287-95.

PMID:
16097802
17.

A review of the enzymology of arsenic metabolism and a new potential role of hydrogen peroxide in the detoxication of the trivalent arsenic species.

Aposhian HV, Zakharyan RA, Avram MD, Sampayo-Reyes A, Wollenberg ML.

Toxicol Appl Pharmacol. 2004 Aug 1;198(3):327-35. Review.

PMID:
15276412
18.

Polymorphisms in the human monomethylarsonic acid (MMA V) reductase/hGSTO1 gene and changes in urinary arsenic profiles.

Marnell LL, Garcia-Vargas GG, Chowdhury UK, Zakharyan RA, Walsh B, Avram MD, Kopplin MJ, Cebrián ME, Silbergeld EK, Aposhian HV.

Chem Res Toxicol. 2003 Dec;16(12):1507-13.

PMID:
14680363
19.

Oxidation and detoxification of trivalent arsenic species.

Aposhian HV, Zakharyan RA, Avram MD, Kopplin MJ, Wollenberg ML.

Toxicol Appl Pharmacol. 2003 Nov 15;193(1):1-8.

PMID:
14613711
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk